Provided by Tiger Trade Technology Pte. Ltd.

ABVC BioPharma, Inc.

1.74
+0.14008.75%
Post-market: 1.800.0600+3.45%18:01 EST
Volume:77.14K
Turnover:132.80K
Market Cap:42.28M
PE:-8.33
High:1.77
Open:1.66
Low:1.66
Close:1.60
52wk High:5.48
52wk Low:0.4000
Shares:24.30M
Float Shares:21.54M
Volume Ratio:0.91
T/O Rate:0.36%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2089
EPS(LYR):-0.4200
ROE:-47.71%
ROA:-17.22%
PB:3.51
PE(LYR):-4.14

Loading ...

ABVC Biopharma Inc. Announces Date for Upcoming Annual Shareholder Meeting

Reuters
·
Yesterday

Aytu BioPharma reports Q2 EPS ($1.05) vs. 13c last year

TIPRANKS
·
Feb 04

In My Forties I Found Out I Have ADHD -- Maybe You Do Too -- WSJ

Dow Jones
·
Jan 24

ABVC Biopharma Issues Amendment to Recent SEC Filing

Reuters
·
Jan 17

Collegium to Present Four Real-World Data Posters at APSARD 2026 Annual Conference

GlobeNewswire
·
Jan 15

Published Peer-Reviewed Study Demonstrates Nexalin’s DIFS™ Neurostimulation Improves Attention and Normalizes Brain Activity in Patients with ADHD

GlobeNewswire
·
Jan 14

BrainsWay Announces FDA Approval of Neurolief’s Proliv™Rx Neuromodulation System for Major Depressive Disorder (MDD)

GlobeNewswire
·
Jan 12

Ark Biopharmaceutical Receives China Marketing Authorization for Azstarys® for the Treatment of ADHD

prnewswire
·
Jan 06

Luo Yonghao Discloses ADHD Diagnosis: May Cease Large-Scale Events if Medication Change Fails or Physical Condition Issues Persist

Deep News
·
Dec 31, 2025

How sport and athletes can show the realities of neurodiversity

cityam
·
Dec 21, 2025

Grant Cardone Says ADHD Isn't A Disorder But 'Misunderstood Genius' — It's A 'Gift From God' That Helps People Chase Multiple Passions

Benzinga
·
Dec 11, 2025

China Resources Double-Crane Pharmaceutical's ADHD Capsules Included in China's Insurance Catalog

MT Newswires Live
·
Dec 09, 2025

Tonix Pharma’s IND Clearance Boosts MDD Treatment Efforts

TIPRANKS
·
Nov 25, 2025

When ADHD Meds Are Just the Start -- WSJ

Dow Jones
·
Nov 22, 2025

For Kids, ADHD Pills Are Often Just the Start -- WSJ

Dow Jones
·
Nov 21, 2025

Millions of Kids Are on ADHD Pills. For Many, It's the Start of a Drug Cascade. -- WSJ

Dow Jones
·
Nov 20, 2025

Jury Convicts Done Global Founder In Adderall Distribution Scheme: WSJ Report

Benzinga
·
Nov 20, 2025

ADHD Startup's Founder Is Found Guilty of Conspiracy in Adderall Case -- WSJ

Dow Jones
·
Nov 19, 2025

Cingulate Inc.’s Promising Market Position Bolstered by Strategic Partnerships and Innovative ADHD Treatment

TIPRANKS
·
Nov 16, 2025

Press Release: Cybin Reports Second Quarter Fiscal Year 2026 Financial Results and Recent Business Highlights

Dow Jones
·
Nov 13, 2025